Elucid Bioimaging Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-10-22.
Elucid Bioimaging Inc. filed an amended Form D notice of an exempt securities offering with the SEC on October 22, 2025. The filing reports $56.23M sold. Its industry group is Biotechnology. It names Blake Richards (Executive Officer), Scott Huennekens (Director), Michael Lesh (Director) (SEC Form D/A, October 22, 2025).
Is this your company?
Sell to companies like Elucid Bioimaging Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-22 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Elucid Bioimaging Inc.
Free to see. No signup.
More on the people and the money behind Elucid Bioimaging Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in October 2025, largest first.
Get an email when Elucid Bioimaging Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Elucid Bioimaging Inc. raises, hires or launches. No email unless you switch it on.
Watch Elucid Bioimaging Inc. →Get the full cited report on Elucid Bioimaging Inc.
What the filing shows about Elucid Bioimaging Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Elucid Bioimaging Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Elucid Bioimaging Inc.'s address as 399 Boylston Street, Suite 400, Boston, MA 02116.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Elucid Bioimaging Inc. →
Amended on 2026-10-27: the amount sold changed from $36,495,008 to $56,235,000; the number of investors changed from 9 to 20. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Elucid Bioimaging Inc. is a registered filer with the SEC (CIK 1585931) and has filed since 2023-11-22. 3 filings are on record, the latest on 2026-10-27.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Elucid Bioimaging Inc.'s Form D of 2025-10-22 names Blake Richards, Scott Huennekens, Michael Lesh and 5 more as its officers, directors or promoters.
Its new offerings report $115.45M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Blake Richards is named as Executive Officer on the Form D that Elucid Bioimaging Inc. filed with the SEC on 22 October 2025, one of 8 people that filing names.
Scott Huennekens is named as Director on the Form D that Elucid Bioimaging Inc. filed with the SEC on 22 October 2025, one of 8 people that filing names.
Michael Lesh is named as Director on the Form D that Elucid Bioimaging Inc. filed with the SEC on 22 October 2025, one of 8 people that filing names.
Richard Kuntz is named as Director on the Form D that Elucid Bioimaging Inc. filed with the SEC on 22 October 2025, one of 8 people that filing names.
Evan Melrose is named as Director on the Form D that Elucid Bioimaging Inc. filed with the SEC on 22 October 2025, one of 8 people that filing names.
Shamiram Feinglass is named as Director on the Form D that Elucid Bioimaging Inc. filed with the SEC on 22 October 2025, one of 8 people that filing names.
Kelly Huang is named as Executive Officer and Director on the Form D that Elucid Bioimaging Inc. filed with the SEC on 22 October 2025, one of 8 people that filing names.
Rajesh Panda is named as Director on the Form D that Elucid Bioimaging Inc. filed with the SEC on 22 October 2025, one of 8 people that filing names.
8 people named on the filing — 2 holding an executive role and 6 as directors only.
Named as of the 2025-10-22 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Elucid Bioimaging Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Elucid Bioimaging Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Elucid Bioimaging Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Elucid Bioimaging Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Elucid Bioimaging Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Elucid Bioimaging Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/elucid-bioimaging-inc-form-d-25000001